PreOmics announces early investors’ exit and closing of Series B financing

Bruker is now a majority investor in PreOmics

19-Jan-2022 - PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation. PreOmics was founded in 2016 by ...

€6 M to develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing

Paris-based biotechnology startup raises Series A financing

26-Feb-2020 - Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of ...

Analytik Jena enters Ultra-High Throughput Market

Access provided by Co-Marketing agreement with Illumina

09-Mar-2017 - Analytik Jena has entered a partnership with Illumina, Inc. headquartered in San Diego. In so doing Analytik Jena gains access to the growing genotyping market currently being served by Illumina’s technologies by offering a production scale solution to provide ultra-high throughput sample ...

Analytik Jena receives major order for diagnostic detection systems from Pakistan

27-May-2013 - Analytik Jena AG has received a large order through its Leipzig-based subsidiary AJ Roboscreen GmbH requiring the delivery of systems for the preparation of samples and the detection of various viruses to eleven clinical laboratories in Pakistan. AJ Roboscreen GmbH secured the invitation to ...

Thermo Fisher Scientific Opens New Manufacturing Facility in China

Expands Global Footprint, Local Production Capabilities to Address Increased Demand from Life Sciences Customers in China and Asia-Pacific Region

19-Nov-2012 - Thermo Fisher Scientific Inc. announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increased ...

OncoMed Pharmaceuticals and Fluidigm annouce strategic collaboration

07-Jan-2010 - OncoMed Pharmaceuticals, Inc. and Fluidigm Corporation announced a new initiative to apply Fluidigm’s microfluidic tools to the analysis of tumor cell heterogeneity, including cancer stem cells. The collaboration will combine Fluidigm’s microfluidic platforms with OncoMed’s proprietary cancer ...

Cell Biosciences Acquires Protein Forest

10-Dec-2009 - Cell Biosciences, Inc. announced that it has acquired Protein Forest, Inc. This strategic acquisition adds Protein Forest's digital ProteomeChip(TM) product line to Cell Biosciences' portfolio of products for protein analysis. Protein Forest, founded in 2002, pioneered a new technology for ...

Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement

Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing

14-Jan-2009 - Illumina and Oxford Nanopore Technologies announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford ...

NorDiag enters distribution and collaboration agreement with Molzym

22-Oct-2008 - NorDiag has entered into two distribution agreements with German based Molzym GmbH & Co KG covering Molzym’s molecular diagnostic products. The first agreement is geographically restrained to USA and Canada, while the second agreement covers the Nordic countries. NorDiag has also entered into a ...

QIAGEN Acquires Biosystems Business from Biotage

Transaction adds fundamental assay technology for high-resolution sequence detection and quantification of genetic variations

06-Oct-2008 - QIAGEN N.V. announced that it has acquired all assets related to the Biosystems business from Biotage AB, a publicly listed developer, manufacturer and distributor of products for genetic analysis and medicinal chemistry headquartered in Uppsala, Sweden. The transaction is valued at approximately ...